Value-Analysis Committee Presentation with Competing Priorities

This template is for practicing a healthcare value-analysis committee presentation after a pilot trial. The learner presents a recommendation for a device replacement and responds to three different priorities in the room: clinical outcomes, total cost and contract terms, and operational feasibility. It is designed to simulate the pressure of a real committee meeting, not a generic pitch. The goal is to leave with conditional approval or a clear next-step commitment.

It is a strong fit for clinicians, clinical educators, sales teams, implementation leads, and account managers who present to hospital committees. It also works for procurement-facing teams that need to explain evidence and rollout plans without sounding overly promotional. If the learner regularly supports capital, device, or product review meetings, this scenario is directly relevant. It is less useful for casual presentation practice that does not involve stakeholder tradeoffs.

Run it before an initial committee presentation, after a pilot trial, and again whenever the evidence package, pricing, or implementation plan changes. It also works well as a recurring rehearsal for new presenters who need practice handling interruptions and competing questions. Because the scenario is conversation-based, repeated attempts help learners refine their opening, evidence framing, and close. The best cadence is tied to real committee milestones rather than a fixed training calendar.

An ad hoc rehearsal usually focuses on slide flow, while this template forces the learner to manage live stakeholder tension. The personas push different agendas, so the presenter has to prioritize, bridge, and redirect without losing control of the room. That makes the practice closer to a real value-analysis meeting, where one answer rarely satisfies everyone equally. It also produces clearer feedback on whether the recommendation is persuasive enough to move the committee forward.

The learner should open with a clear recommendation, then support it with clinical evidence, financial impact, and an implementation plan. They should name tradeoffs directly instead of hiding them, especially when the pilot data is positive but not perfect. The strongest attempts acknowledge each stakeholder’s concern before answering it. The close should ask for a specific decision, such as conditional approval, a follow-up review, or a defined pilot expansion.

Yes. The situation can be adapted for implants, capital equipment, monitoring devices, or consumables, as long as the committee structure stays the same. You can swap in service-line-specific evidence, different contract terms, and a rollout plan that matches the local workflow. The personas can also be tuned to be more skeptical or more collaborative depending on the audience. Keep the learner objective focused on balancing priorities and securing a next step.

The most common mistake is leading with product features instead of a recommendation and decision path. Another is over-indexing on clinical data while ignoring cost, implementation, or adoption barriers. Learners also often answer the procurement lead too vaguely on total cost or contract terms. This scenario makes those gaps visible quickly because the committee members react differently to each omission.

Yes, because the operations administrator will usually press on implementation details, training, and workflow impact. The learner has to explain how the device will be adopted after approval, not just why it is clinically attractive. That makes the scenario useful for teams that need to show they can support change after the committee says yes. It is especially helpful when approval depends on a credible transition plan.